Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05078840
What this trial is testing

PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors

Who this might be right for
Lymphoma, Non-Hodgkin's, Adult
Grupo Argentino de Tratamiento de la Leucemia Aguda 75
Testing effectiveness (Phase 2)Study completedNCT00447980
What this trial is testing

Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Neurotech Pharmaceuticals 73
Not applicableStudy completedNCT03561688
What this trial is testing

Foot Orthotic for Early Stage Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisRheumatoid Arthritis of Foot (Disorder)
Regionshospital Nordjylland 27
Not applicableLooking for participantsNCT07135661
What this trial is testing

Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy

Who this might be right for
Breast CancerProton Therapy
Shanghai Proton and Heavy Ion Center 312
Large-scale testing (Phase 3)UnknownNCT04665986
What this trial is testing

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT05180006
What this trial is testing

Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 33
Not applicableUnknownNCT03797248
What this trial is testing

Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer

Who this might be right for
Early-stage Breast Cancer
Chang Gung Memorial Hospital 310
Not applicableStudy completedNCT04491578
What this trial is testing

An Advance Care Planning Programme for Persons With Early Stage Dementia in the Community

Who this might be right for
Dementia MildMild Cognitive Impairment
Hong Kong Metropolitan University 100
Not applicableWithdrawnNCT00084578
What this trial is testing

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Who this might be right for
Bladder Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00698035
What this trial is testing

Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients

Who this might be right for
Sexual Dysfunction, Physiological
University of California, San Francisco 76
Not applicableLooking for participantsNCT06279026
What this trial is testing

UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 15
Testing effectiveness (Phase 2)Looking for participantsNCT04891068
What this trial is testing

BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

Who this might be right for
Breast Cancer InvasiveEarly-stage Breast CancerHigh Risk Breast Carcinoma
University of Illinois at Chicago 40
Not applicableStudy completedNCT01078415
What this trial is testing

Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Angiodynamics, Inc. 26
Not applicableStudy completedNCT06536140
What this trial is testing

The Lived Experiences of Persons With Early Stage Non-small Cell Lung Cancer and Their Significant Other(s) Following Surgery: a Rapid Ethnographic Approach

Who this might be right for
Lung Cancer
Hasselt University 16
Very early researchStudy completedNCT01434342
What this trial is testing

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Who this might be right for
Lung CancerTobacco Use DisorderBreast Cancer+2 more
Wake Forest University Health Sciences 146
Not applicableUnknownNCT01157962
What this trial is testing

Sentinel Concept in Early Stage Cervical Cancer

Who this might be right for
Cervical Cancer
Charite University, Berlin, Germany 1,600
Early research (Phase 1)Study completedNCT02603003
What this trial is testing

The"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
Shanghai University of Traditional Chinese Medicine 218
Not applicableLooking for participantsNCT06781281
What this trial is testing

NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.

Who this might be right for
Breast Cancer Invasive
Henan Cancer Hospital 709
Testing effectiveness (Phase 2)Ended earlyNCT03968419
What this trial is testing

This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 88
Testing effectiveness (Phase 2)WithdrawnNCT04648189
What this trial is testing

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

Who this might be right for
Lung CancerSurgeryCirculating Tumor Cell
The Netherlands Cancer Institute
Next Page